1333P Dose and schedule modifications of carboplatin plus nab-paclitaxel for elderly patients with squamous non-small cell lung cancer from the CAPITAL study

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; pp. S1020 - S1021
Main Authors Saito, G., Kogure, Y., Kada, A., Hashimoto, H., Atagi, S., Takiguchi, Y., Saka, H., Ebi, N., Inoue, A., Kurata, T., Yamanaka, T., Ando, M., Shibayama, T., Itani, H., Nishii, Y., Fujita, Y., Yamamoto, N., Gemma, A.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2021
Online AccessGet full text

Cover

Author Kogure, Y.
Fujita, Y.
Gemma, A.
Saka, H.
Saito, G.
Ando, M.
Ebi, N.
Takiguchi, Y.
Shibayama, T.
Yamanaka, T.
Kada, A.
Hashimoto, H.
Itani, H.
Nishii, Y.
Inoue, A.
Yamamoto, N.
Atagi, S.
Kurata, T.
Author_xml – sequence: 1
  givenname: G.
  surname: Saito
  fullname: Saito, G.
  organization: Department of Respirology, Chiba University Hospital, Chiba, Japan
– sequence: 2
  givenname: Y.
  surname: Kogure
  fullname: Kogure, Y.
  organization: Department of Respiratory Medicine, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
– sequence: 3
  givenname: A.
  surname: Kada
  fullname: Kada, A.
  organization: Clinical Research Center, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
– sequence: 4
  givenname: H.
  surname: Hashimoto
  fullname: Hashimoto, H.
  organization: Core Laboratory, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
– sequence: 5
  givenname: S.
  surname: Atagi
  fullname: Atagi, S.
  organization: Department of Thoracic Oncology, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan
– sequence: 6
  givenname: Y.
  surname: Takiguchi
  fullname: Takiguchi, Y.
  organization: Department of Medical Oncology, Chiba University Hospital, Chiba, Japan
– sequence: 7
  givenname: H.
  surname: Saka
  fullname: Saka, H.
  organization: Department of Respiratory Medicine, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
– sequence: 8
  givenname: N.
  surname: Ebi
  fullname: Ebi, N.
  organization: Department of Respiratory Oncology, Iizuka Hospital, Fukuoka, Japan
– sequence: 9
  givenname: A.
  surname: Inoue
  fullname: Inoue, A.
  organization: Department of Palliative Medicine, Tohoku University School of Medicine, Miyagi, Japan
– sequence: 10
  givenname: T.
  surname: Kurata
  fullname: Kurata, T.
  organization: Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan
– sequence: 11
  givenname: T.
  surname: Yamanaka
  fullname: Yamanaka, T.
  organization: Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan
– sequence: 12
  givenname: M.
  surname: Ando
  fullname: Ando, M.
  organization: Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan
– sequence: 13
  givenname: T.
  surname: Shibayama
  fullname: Shibayama, T.
  organization: Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama, Japan
– sequence: 14
  givenname: H.
  surname: Itani
  fullname: Itani, H.
  organization: Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Ise, Japan
– sequence: 15
  givenname: Y.
  surname: Nishii
  fullname: Nishii, Y.
  organization: Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan
– sequence: 16
  givenname: Y.
  surname: Fujita
  fullname: Fujita, Y.
  organization: Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan
– sequence: 17
  givenname: N.
  surname: Yamamoto
  fullname: Yamamoto, N.
  organization: Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University, Wakayama, Japan
– sequence: 18
  givenname: A.
  surname: Gemma
  fullname: Gemma, A.
  organization: Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
BookMark eNqFkE1u2zAQhYkgAeqkOUKBuYBUUhJpcRUY7l8AA80iXRMUOaxpUKRKSm19mN61Mtx9NzPAw7yHed89uY0pIiHvGK0ZZeL9qdZxlUzd0IbVtK-ZbLsbsmFcyKqnHbslGyqbttrytntD7ks5UUqFbOSG_GFt277Ah1QQdLRQzBHtEhDGZL3zRs8-xQLJgdF5SFNYhQhTWApEPVSTNsHP-jcGcCkDBos5nGFarzDOBX75-Qjlx6LHdHGkWJVRhwAG1xGW-H2NjQYzuJxGmI8I-93L8-vuAGVe7PktuXM6FHz8tx_It08fX_dfqsPXz8_73aEyrJNdJZstQ06lNrrZisZpxh0zQnAmLTaoDeeWd04ypJ3ukQ9CyAHF0Atk2DPaPhB-zTU5lZLRqSn7UeezYlRdGKuTujJWF8aK9urCePU9XX24PvfTY1bFrMUNWp_RzMom_5-Ev8_oi7g
ContentType Journal Article
Copyright 2021 European Society for Medical Oncology
Copyright_xml – notice: 2021 European Society for Medical Oncology
DBID AAYXX
CITATION
DOI 10.1016/j.annonc.2021.08.1934
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1569-8041
EndPage S1021
ExternalDocumentID 10_1016_j_annonc_2021_08_1934
S0923753421041648
GroupedDBID ---
-E4
.2P
.86
.I3
.XZ
.ZR
08P
0R~
0U7
1TH
23M
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
6J9
70D
AABJS
AABMN
AAEDW
AAESY
AAIAV
AAIYJ
AAJKP
AAJQQ
AAKAS
AAKUH
AAMVS
AAOGV
AAPNW
AAUQX
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVKL
ABZBJ
ACGFO
ACGFS
ACIMA
ACMRT
ACPQN
ACPRK
ACUFI
ACUTO
ADBBV
ADEIU
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADYVW
ADZCM
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFIYH
AFOFC
AFXEN
AGINJ
AGKEF
AGKRT
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AIKOY
AITUG
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
AQKUS
ASMCH
ASPBG
ATTQO
AVWKF
AWCFO
AXUDD
AZFZN
AZQFJ
BAWUL
BAYMD
BEYMZ
BGNMA
BGYMP
BHONS
BTRTY
BVRKM
BZKNY
C1A
CAG
CASEJ
CDBKE
CKLRP
COF
CS3
CZ4
DAKXR
DIK
DILTD
DL5
DPORF
DPPUQ
D~K
E3Z
EBS
EE~
EJD
EX3
F9B
FDB
FEDTE
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
I09
IH2
IHE
IOX
J21
KAQDR
KC5
KDC
KOM
KOP
KQ8
KSI
KSN
LAK
M-Z
M41
M49
M4Y
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOYVH
NTWIH
NU-
NU0
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OVD
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RPX
RW1
RXO
RZC
RZE
RZF
RZO
SDH
TCURE
TEORI
TJX
TMA
TR2
U2A
W8F
WOQ
WOW
X7H
YAYTL
YFH
YKOAZ
ZKX
ZXP
~91
0SF
AALRI
AAYXX
ADVLN
AEHUL
AFETI
AFJKZ
AFSHK
AKRWK
CITATION
H13
ID FETCH-LOGICAL-c1494-9271e509aca2762fa15f1c66519de2eac55d54f91e04a8e5b669be6b86e1e8103
IEDL.DBID ABVKL
ISSN 0923-7534
IngestDate Thu Sep 26 18:50:19 EDT 2024
Fri Feb 23 02:42:59 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1494-9271e509aca2762fa15f1c66519de2eac55d54f91e04a8e5b669be6b86e1e8103
OpenAccessLink https://doi.org/10.1016/j.annonc.2021.08.1934
ParticipantIDs crossref_primary_10_1016_j_annonc_2021_08_1934
elsevier_sciencedirect_doi_10_1016_j_annonc_2021_08_1934
PublicationCentury 2000
PublicationDate September 2021
2021-09-00
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: September 2021
PublicationDecade 2020
PublicationTitle Annals of oncology
PublicationYear 2021
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
SSID ssj0006929
Score 2.4120715
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S1020
Title 1333P Dose and schedule modifications of carboplatin plus nab-paclitaxel for elderly patients with squamous non-small cell lung cancer from the CAPITAL study
URI https://dx.doi.org/10.1016/j.annonc.2021.08.1934
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELX6ISEuCAqIUqjm0Ku7a6_tTY7LQum3KtGivUV2MpFapdntpiuVH8N_5XmTLSAhDj3G0kSOx3l-bzweC7EHSuFCqqy0Q59K45NS-qHXkm0BLhcKKIgoFM_O3eGVOZ7YyZoYr87CxLTKDvtbTF-iddfS60azN7u-7n3rg5uAbBuIFrAKk6yLTQ32i79zc_Tp-8npIyC7VLcl9_RARoPfB3l6N_u-hsyOtQz1spYn-Iz59xL1x7Jz8FK86PgijdouvRJrXG-JZ2fdjvhr8RPqb3BBn6cNk68LgljF4lEx3U6LmAXUBuRoWlLu52E6i6lvNc2qRUO1DxKKOVbpfuCKwF6J453d1Q_qqq02FMO01NwtfIwQEL5BNre-qijG-6kCUOC1GLI5xWMqBDJJ49HF0eXolJZ1a9-Iq4Mvl-ND2V25IHNIJSNTPVQMDuFzrwGTpVe2VLlz4HkFa4C0tYU1Zaq4D7-yDc6lgV1IHCtOVH_wVmygL_xOkMpVbjzadZqYkJbBepiAf7ApypJ5W-yvRjmbtZU1slXK2U3WuiWLbsn6SRbdsi2SlS-yv6ZIBvT_v-n7p5vuiOfxsU0r-yA27ucL_ggech92u3m2K9a_TtQvoivedQ
link.rule.ids 315,783,787,27581,27936,27937,45675
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED5BkYCXaeOHYGPbPezVtE5tN3nsylAZLUKiIN4sO7lIoJCWhkrbH7P_decm3YY08cCro4scn_X5-y53Z4AvTCmMT6QWuucSoVycC9dzkSCdMZfzGSuIIBTHF2Z4rb7f6ts1GKxqYUJaZYP9NaYv0boZaTer2Z7d3bWvOsxNmGwrFi3MKlS8DhvMBnq6BRv9rzfnoz-AbJKobrkXdUUw-FvI074_diXL7NDLMFr28mQ-o_5_RP1z7Jy-hTcNX8R-PaV3sEblDmyOmz_iu_CL1V_3Ek-mFaErM2SxyodHQfgwzUIWUB2Qw2mOqZv76SykvpU4KxYVls4LVsyhS_cPKpDZK1K4s7v4iU231QpDmBarx4ULEQLkbxDVgysKDPF-LBgo-LW8ZHMMZSrIZBIH_cuzSX-Ey761e3B9-m0yGIrmygWRslRSIol6kphDuNRFDJO5kzqXqTHM8zKKGKS1zrTKE0kd9itpb0ziyfjYkKRYdrr70OK50AGgTGWqHI9HSax8knvt2IT5B6ksz4kO4Xi1ynZWd9awq5Sze1u7xQa32E5sg1sOIV75wj7bIpbR_2XT9683_Qxbw8l4ZEdnF-cfYDs8qlPMjqD1NF_QR-YkT_5Ts-d-A_q54HI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1333P+Dose+and+schedule+modifications+of+carboplatin+plus+nab-paclitaxel+for+elderly+patients+with+squamous+non-small+cell+lung+cancer+from+the+CAPITAL+study&rft.jtitle=Annals+of+oncology&rft.au=Saito%2C+G.&rft.au=Kogure%2C+Y.&rft.au=Kada%2C+A.&rft.au=Hashimoto%2C+H.&rft.date=2021-09-01&rft.issn=0923-7534&rft.volume=32&rft.spage=S1020&rft.epage=S1021&rft_id=info:doi/10.1016%2Fj.annonc.2021.08.1934&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_annonc_2021_08_1934
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon